Retatrutide Trial Results: Triple-Hormone Drug Cut Weight by Up to About 20% in People With Type 2 Diabetes
In the phase 3 TRIUMPH-2 trial, experimental drug retatrutide cut weight by up to about 20% and lowered blood sugar in adults with type 2 diabetes.